When did ARYx Therapeutics go public and at what price?
ARYx Therapeutics went public in November 2007 at an IPO price of $10.00 per share.
On which exchange is ARYx Therapeutics listed and what is the ticker symbol?
ARYx Therapeutics is listed on the NASDAQ Global Market under the ticker symbol "ARYX."
What year was ARYx Therapeutics incorporated and in what state?
ARYx Therapeutics was originally incorporated in California in February 1997 and was reincorporated in Delaware in August 2007.
Where is ARYx Therapeutics headquartered?
Our corporate headquarters are in Fremont, California. Our mailing address is:
ARYx Therapeutics, Inc.
6300 Dumbarton Circle
Fremont, CA 94555
How can I invest in ARYx Therapeutics?
ARYx Therapeutics' common stock can be bought or sold through a stockbroker or financial institution that offers brokerage services.
Who do I contact for questions about my stock certificates or records related to my shares?
ARYx Therapeutics' transfer agent is Computershare Investor Services LLC. Contact them for financial literature or stockholder services, to transfer stock, to report lost stock certificates, to inquire about trading restrictions ("legends"), or to change your address. Current stockholders can get full portfolio access to their ARYx Therapeutics account(s) by registering on the Computershare Web site.
By telephone:
In the U.S. tollfree: 1-800-662-7232
Outside the U. S direct dial: +11-781-575-2879
By postal mail:
Computershare Investor Services LLC
PO Box 43078
Providence, RI 02940-3078
By overnight delivery:
Computershare Investor Services LLC
250 Royall Street
Canton, MA 02021
Where are my stock certificates?
Most ARYx Therapeutics stockholders hold their stock in "Street Name" (i.e. their broker) and do not receive stock certificates. If you would like to request a stock certificate be mailed to you, contact your broker or our transfer agent, Computershare Investor Services.
Does ARYx Therapeutics pay a cash dividend?
No, ARYx Therapeutics has never declared a cash dividend.
Do you have a DRIP (Dividend Reinvestment Plan)?
No, ARYx Therapeutics does not pay a dividend and therefore does not have such a program.
Does ARYx Therapeutics have a direct stock purchase plan?
No, ARYx Therapeutics does not have a direct purchase plan. Shares of ARYx Therapeutics can be purchased through your stock broker or stock purchase service of your choice.
Has ARYx Therapeutics had any stock splits?
ARYx Therapeutics has not had any stock splits since going public in November 2007.
What is the CUSIP number for our common stock?
ARYx Therapeutics' common stock CUSIP number is 043387-109.
Who are the financial analysts that follow ARYx Therapeutics?
Please go to our section entitled Analyst Coverage for a listing of analysts that cover ARYx Therapeutics.
Who is ARYx Therapeutics' Independent Auditors?
Ernst and Young LLP
1001 Page Mill Road
Palo Alto, CA 94304
Who is ARYx Therapeutics' outside Legal Counsel?
Cooley Godward Kronish LLP
Five Palo Alto Square
3000 El Camino Real
Palo Alto, CA 94306
Who can I contact about specific investor relations issues?
If you are unable to find the information you are looking for about ARYx Therapeutics on this Website, you may contact the following:
David Nagler
Vice President Corporate Affairs
Tel: 510-585-2202
E-Mail: dnagler@aryx.com
When is your annual meeting of stockholders?
We have not yet set our annual meeting date. We will post it on our Website when the date is determined.
Where can I get access to ARYx Therapeutics' financial and other reports filed with the SEC?
Please go to the SEC Filings section of our Website.
Who are the members of ARYx Therapeutics' Board of Directors?
Please see the list and biographies of our Directors in the Board of Directors section of our Website.
What are the Committees of the Board of Directors and does each Committee have a written charter?
The Board of Directors has the following standing Committees: Compensation, Audit, and Nominating and Governance. The Charters for each of these Committees can be found in the Corporate Governance Section of our Website.
Do you have another question that hasn't been answered?
Please submit your question using the form below. Fields marked with an * are required.
show all
hide all
Print page 
Email page 
Shareholder Briefcase
Printed Materials
Download Library
Glossary
RSS News Feeds
